oxotremorine has been researched along with Neuroectodermal Tumors, Primitive, Peripheral in 2 studies
Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.
Neuroectodermal Tumors, Primitive, Peripheral: A group of highly cellular primitive round cell neoplasms which occur extracranially in soft tissue and bone and are derived from embryonal neural crest cells. These tumors occur primarily in children and adolescents and share a number of characteristics with EWING SARCOMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Palmer, RK | 1 |
| Yule, DI | 1 |
| McEwen, EL | 2 |
| Williams, JA | 1 |
| Fisher, SK | 2 |
| Lovell, SC | 1 |
| Landon, RE | 1 |
2 other studies available for oxotremorine and Neuroectodermal Tumors, Primitive, Peripheral
| Article | Year |
|---|---|
Agonist-specific calcium signaling and phosphoinositide hydrolysis in human SK-N-MCIXC neuroepithelioma cells.
Topics: Adenosine Triphosphate; Calcium; Endothelins; Humans; Hydrolysis; Neuroectodermal Tumors, Primitive, | 1994 |
Cyclic AMP potentiates receptor-stimulated phosphoinositide hydrolysis in human neuroepithelioma cells.
Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Cyclic AMP; Drug Synergism; Endothelins; Humans; H | 1992 |